Indication

Seborrheic dermatitis

Seborrheic dermatitis is a common, chronic relapsing inflammatory skin disease of the integumentary system that predominantly affects areas with high concentrations of sebaceous glands, including the scalp, face, ears, and chest. Read more about Seborrheic dermatitis

1,035 drugs 233 manufacturers

Advertisement

Drugs that treat it

Common Seborrheic dermatitis therapies.

Showing 685–693 of 1,035 drugs

HALCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
Mylan Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Seborrheic dermatitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Seborrheic dermatitis.

Seborrheic dermatitis is a common, chronic relapsing inflammatory skin disease of the integumentary system that predominantly affects areas with high concentrations of sebaceous glands, including the scalp, face, ears, and chest.

It displays a bimodal age distribution, occurring as a self-limiting condition in infants—frequently referred to as cradle cap—and as a chronic papulosquamous disorder in adolescents and adults.

Clinically, it presents with erythematous or hypopigmented patches covered by characteristic greasy, white-to-yellow scales that can be associated with variable pruritus.

The underlying pathophysiology involves an inflammatory response to the proliferation of commensal *Malassezia* yeast species, altered skin surface lipid composition, epidermal barrier disruption, and host immune susceptibility.

Personalize your experience

Follow Seborrheic dermatitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it